Comparison

EBV BZLF-1 190-197 (HLA-B*08:01) European Partner

Item no. EP07965_1
Manufacturer peptides & elephants
Amount 1 mg
Quantity options 1 mg 5 mg
Category
Type Peptides
Specific against other
Purity 0,95
Sequence RAKFKQLL
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias RAKFKQLL Trans-activator protein BZLF1 HLA-B*08:01 Autoimmune disease, Burkitt's lymphoma, Hodgkin's lymphoma, Nasopharyngeal carcinoma, T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response othe
Available
Manufacturer - Applications
T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response
Storage Conditions
Store dry at -20°C
C-Terminus
NH2
N-Terminus
H
Counter-Ion
TFA
Description
Antigen peptide RAKFKQLL for stimulation of human EBV BZLF-1(190-197)-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-B*0801 allele. RAKFKQLL is a linear peptidic epitope (epitope ID53128) studied as part of Trans-activator protein BZLF1 from Human herpesvirus 4 (Epstein Barr virus). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays
Gene
BZLF1
Indication
Autoimmune disease, Burkitt's lymphoma, Hodgkin's lymphoma, Nasopharyngeal carcinoma
Protein
Trans-activator protein BZLF1
Allele
HLA-B*08:01

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close